Treatment of atrophic vaginitis

Therapy

Volumn 4, Issue 3, 2007, Pages 349-353

  Castelo Branco, Camil ^a   Rostro, Fabiola ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Hormonal therapy; Local therapy; Menopause; Vaginitis

Indexed keywords

ALPHA TOCOPHEROL; BELLADONNA ALKALOID; CHINESE DRUG; CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL ACETATE; ESTROGEN; FOLLITROPIN; GESTAGEN; LUBRICATING AGENT; LUTEINIZING HORMONE; LYCOPODIUM EXTRACT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; VITAMIN D;

ACUPUNCTURE; ATROPHIC VAGINITIS; BLEEDING; CLINICAL FEATURE; CLINICAL TRIAL; COITUS; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DYSPAREUNIA; ENDOMETRIUM HYPERPLASIA; ESTROGEN DEFICIENCY; FOLLITROPIN BLOOD LEVEL; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; INDIVIDUALIZATION; INTIMACY; LABORATORY TEST; LOW DRUG DOSE; LUBRICATION; MASTALGIA; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PATIENT SATISFACTION; PH; PHYSICAL EXAMINATION; POSTMENOPAUSE; PREMENOPAUSE; QUALITY OF LIFE; REVASCULARIZATION; REVIEW; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; URINARY TRACT; VAGINA; VAGINA ATROPHY; VAGINA EPITHELIUM; VAGINA RING; VAGINAL BURNING SENSATION; VAGINAL DRYNESS; VAGINAL PRURITUS; VAGINITIS;

EID: 34248665863     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/14750708.4.3.349     Document Type: Review

References (32)

1. Beers MH, Berkow R: Gynecology and obstetrics. In: The Merck Manual of Diagnosis and Therapy (17th Edition). Merck Research Laboratories, Whitehouse Station, NJ, USA 1942-1944 (1999).
2. Bachmann GA: Urogenital aging: an old problem newly recognized. Maturitas (Suppl. 22), S1-S5 (1995).
3. Bachmann GA, Nevadunsky NS: Diagnosis and treatment of atrophic vaginitis. Am. Fam. Physician 61, 3090-3096 (2000).
4. Greendale GA, Judd HL: The menopause: health implications and clinical management. J. Am. Geriatr. Soc. 41, 426-436 (1993).
5. Nilsson K, Risberg B, Heimer G: The vaginal epithelium in the postmenopause-cytology, histology, and pH as methods of assessment. Maturitas 21, 51-56 (1995).
6. Semmens JP, Wagner G: Estrogen deprivation and vaginal function in postmenopausal women. J. Am. Med. Assoc. 248, 445-448 (1982).
7. Rymer J, Morris EP: Extracts from "clinical evidence": menopausal symptoms. BMJ 321, 1516-1519 (2000).
8. Bachmann G, Nevadunsky N: Diagnosis and treatment of atrophic vaginitis. Am. Fam. Physician 61(10), 3090-3096 (2000).
9. Willhite LA, O'Connell MB: Urogenital atrophy: prevention and treatment. Pharmacotherapy 21, 464-480 (2001).
10. Forsberg JG: A morphologist's approach to the vagina - age-related changes and estrogen sensitivity. Maturitas 22, S7-15 (1995).
11. Maloney C: Estrogen and recurrent UTI in postmenopausal women. Am. J. Nurs. 102, 44-53 (2002).
12. Sarrel PM: Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause. J. Womens Health Gend. Based Med. 9, S25-S32 (2000).
13. Berman JR, Goldstein I: Female sexual dysfunction. Urol. Clin. N. Am. 28, 405-416 (2001).
14. Freedman MA: Quality of life and menopause: the role of estrogen. J. Womens Health (Larchmt.) 11, 703-718 (2002).
15. Bachmann GA, Leiblum SR, Grill J: Brief sexual inquiry in gynecological practice. Obstet. Gynecol. 73, 425-427 (1989).
16. Avis NE, Stellato R, Crawford S et al.: Is There a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc. Sci. Med. 52, 345-356 (2001).
17. Kalogeraki A, Tamiolakis D: Cigarette smoking and vaginal atrophy in postmenopausal women. In Vivo 10(6), 597-600 (1996).
18. Baron JA, La Vecchia C, Levi F: The antiestrogenic effect of cigarette smoking in women. Am. J. Obstet Gynecol. 162, 502-514 (1990).
19. Monfrecola G, Riccio G, Savarese C, Posteraro G, Procaccini EM: The acute effect of smoking on cutaneous microcirculation blood flow in habitual smokers and nonsmokers. Dermatology 197(2), 115-118 (1998).
20. Cuadros JL, Llaneza P, Mateu S: Demografía y epidemiologia del climaterio en España. In: AEEM. Libro Blanco del Climaterio en Epaña. Bernard-Krieg (Ed.), Madrid, Spain 15-33 (2000).
21. Pandit L, Ouslander JG: Postmenopausal vaginal atrophy and atrophic vaginitis. Am. J. Med. Sci. 314, 228-231 (1997).
22. Lethaby A, Suckling J, Barlow D et al.: Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst. Rev. (3), CD000402 (2004).
23. Henzl MR, Loomba PK: Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice. J. Reprod. Med. 48, 525-540 (2003).
24. Archer DF: Percutaneous 17β-estradiol gel for the treatment of vasomotos symptoms in postmenopausal women. Menopause 10, 516-522 (2003).
25. Suckling J, Lethaby A, Kennedy R: Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst. Rev.(4), CD001500 (2006).
26. Rioux JE, Devlin C, Gelfand MM, Steimberg WM, Hepburn DS. 17 β-estradiol versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 7(3), 140-142 (2000).
27. Kendall A, Dowsett M, Folkerd E, Smith I: Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann. Oncol. 17(4), 584-587 (2006).
28. Mainini G, Scaffa C, Rotondi M, Messalli EM, Quirino L, Ragucci A: Local estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose 17 β-estradiol vaginal tablets. Clin. Exp. Obstet. Gynecol. 32(2), 111-113 (2005).
29. Speroff L: Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms. Obstet. Gynecol. 102, 823-834 (2003).
30. Ballagh SA: Vaginal rings for menopausal symptom relief. Drugs Aging 21(12), 757-766 (2004).
31. Johnston SL, Farrell SA, Bouchard C et al.: Detection and management of vaginal atrophy. J. Obstet. Gynaecol. Can. 26(5), 503-515 (2004).
32. Morali G, Polatti F, Metelitsa EN, Mascarucci P, Magnani P, Marre GB: Open, on-controlled clinical studies to asses the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arzneimittelforschung 56 (3), 230-238 (2006).